Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force

KW Miskowiak; N Yalin; I Seeberg; KE Burdick; V Balanzá-Martínez; CDM Bonnin; CR Bowie; AF Carvalho; A Dols; K Douglas; P Gallagher; G Hasler; LV Kessing; B Lafer; KE Lewandowski; C López-Jaramillo; A Martinez-Aran; RS McIntyre; RJ Porter; SE Purdon; A Schaffer; T Sumiyoshi; IJ Torres; TE Van Rheenen; LN Yatham; AH Young; E Vieta; PRA Stokes

Journal article

Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force

KW Miskowiak, N Yalin, I Seeberg, KE Burdick, V Balanzá-Martínez, CDM Bonnin, CR Bowie, AF Carvalho, A Dols, K Douglas, P Gallagher, G Hasler, LV Kessing, B Lafer, KE Lewandowski, C López-Jaramillo, A Martinez-Aran, RS McIntyre, RJ Porter, SE Purdon Show all

Bipolar Disorders | Published : 2022

DOI: 10.1111/bdi.13247

Download PDF

Abstract

Background: Developing treatments for cognitive impairment is key to improving the functioning of people with mood disorders. Neuroimaging may assist in identifying brain-based efficacy markers. This systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force examines the evidence from neuroimaging studies of pro-cognitive interventions. Methods: We included magnetic resonance imaging (MRI) studies of candidate interventions in people with mood disorders or healthy individuals, following the procedures of the Preferred Reporting Items for Systematic reviews and Meta-Analysis 2020 statement. Searches were conducted on PubMed/MEDLINE, ..

View full abstract